Premarket Stock Movers — July 22, 2026: Why LABT, INLF, INM, CHAI & ZCMD Are Surging

LABT — Lakewood-Amedex Biotherapeutics Inc. (+224.2%)

Lakewood-Amedex Biotherapeutics is surging +224.2% to $5.90 in premarket trading this morning, on volume of 34,394,320 shares — roughly 101× its 20-day average of 340,818. That is an extraordinary flood of premarket activity into a stock with a market cap of only $12.7 million.

Why it's moving: According to a Yahoo Finance headline dated this morning, Lakewood-Amedex Biotherapeutics is highlighting its Nu-3 Resistance Data in response to the National Action Plan of the Presidential Advisory Council on Combating Antibiotic Resistant Bacteria. That policy-level spotlight on antibiotic resistance — a major public-health priority — appears to be the catalyst drawing attention to the company's pipeline.

On the technical side, LABT's prior-day chart carried a conviction score of 0/100 and a grade of D, with RSI at 40 and the stock sitting 79% below its 52-week high. There was no established lane signal heading into this move. In short, this is not a technically-prepared breakout — it is a news-driven spike into a very depressed stock. The short-squeeze score is just 1/100 with only 37,772 shares short and 0.1 days to cover, so a squeeze dynamic is not meaningfully contributing here.

The risk is real and significant. LABT is a micro-cap ($12.7M market cap) deep in distressed-chart territory, with a D-grade setup and zero conviction score before this morning. Three recent 424B3 resale filings on record suggest potential share-supply overhang. Moves of 200%+ on micro-cap names in premarket — with lighter-than-normal volume and wider bid/ask spreads — are among the most volatile and mean-reverting setups in markets. The regular session has not yet opened.

INLF — INLIF Ltd (+56.1%)

INLIF Ltd, an Industrials-sector company, is trading up +56.1% to $3.45 premarket on 17,017,633 shares. Notably, that is actually below its 20-day average volume of 253 million shares — meaning while the price spike is dramatic, the name already sees unusually heavy trading activity in normal sessions.

Why it's moving: There are no news headlines on file for INLF this morning, and its most recent SEC filing is a routine 6-K from July 7. The catalyst is unclear, and the move appears to be technically and momentum-driven. What the data does show is a series of recent insider-adjacent purchases: HRT Financial LP, a quantitative trading firm, made three separate Form 4 buys totaling roughly 4.4 million shares across June 24–26. While these are disclosed institutional buys, they were made at prices well below today's premarket level.

The prior-day chart shows a conviction score of 31/100, RSI 47, ADX 42 (signaling a trending environment), and a mixed MA stack — not a cleanly bullish setup, but showing some directional momentum. The RS rating of 97 is a standout, meaning INLF has been outperforming nearly the entire US market on a relative-strength basis. The squeeze score is 40/100 with a tiny free float of just 0.4% — that means almost no shares are freely tradeable by the public. A low float (few shares available to trade) can amplify price swings dramatically in both directions, even on modest order flow.

With no confirmed catalyst and a near-zero float, INLF is susceptible to violent reversals. The stock sits 65% below its 52-week high, and the D grade underlines the underlying technical weakness.

INM — InMed Pharmaceuticals Inc. (+45.3%)

InMed Pharmaceuticals is up +45.3% to $2.18 premarket on volume of 36,858,997 shares — an astounding 977× its 20-day average of 37,708. That is one of the most extreme relative-volume readings in this morning's mover list.

Why it's moving: The data points to a merger catalyst. INMed filed a Form 425 (a merger-related communication) on July 20, and a separate 8-K noting an agreement on July 10, with an S-4 merger registration filed July 2. A Yahoo Finance headline from this morning references Mentari Therapeutics announcing a $200 million private placement for a migraine prevention pipeline — this appears connected to the InMed / Mentari transaction activity evident in the SEC filings. Merger announcements, especially those involving significant capital raises, frequently trigger sharp premarket moves in the target company's shares.

The prior-day technical setup is arguably the strongest in today's mover list: conviction 63/100, grade B, RSI 46, ADX 42, a bullish MA stack (short-term moving averages above long-term ones), and an RS rating of 90. The trend-template score of 4 and technical rank of 74 suggest INM was already setting up constructively before this morning's news. Multiple insider buys from Vivo Opportunity LLC and ADAR1 Capital Management in mid-July add a smart-money signal layer — the smart-money score is 48/100.

The days-to-cover ratio is 4.3 — meaning at average volume, short sellers would need 4.3 days to buy back their borrowed shares. That is the highest days-to-cover reading in today's group, and in the context of a big gap up, it could add squeeze pressure (short sellers rushing to cover by buying, which adds more upward force). However, INM's market cap is only $5 million, making this still a very high-risk situation.

CHAI — Core AI Holdings, Inc. (+44.2%)

Core AI Holdings is surging +44.2% to $0.56 premarket on 60,789,970 shares — nearly 98× its 20-day average of 618,299. CHAI is also trading under a Short Sale Restriction (SSR), which is triggered automatically when a stock falls more than 10% from its prior close; SSR limits the ability of short sellers to add new downward pressure by restricting short sales to upticks only.

Why it's moving: Multiple sources point clearly to a HomeGPT expansion catalyst. A Benzinga headline from this morning reports Core AI Holdings' stock "rallied nearly 132% after hours" — this premarket session is the continuation of that after-hours move. Headlines from July 21 detail that Core AI Holdings is elevating its HomeGPT product as an "AI Residential Decision Layer" amid the shifting U.S. housing market, with one report noting that a single home photo can generate multiple design concepts through HomeGPT. The company filed a 6-K with the SEC on July 21 coinciding with these announcements.

Prior to this catalyst, the technical picture was weak: conviction 43/100, RSI 31 (oversold territory), technical rank of just 1, and the stock sitting a striking 95.4% below its 52-week high. The free float is 27% and the squeeze score is 31/100. A gap up (when a stock opens significantly above its prior close, leaving a price "gap" on the chart) on an AI-product announcement into a heavily oversold, low-priced name is a classic high-volatility setup — but the prior trend was sharply negative.

CHAI trades below $1.00, which puts it in "penny stock" territory. Stocks in this price range can move in large percentage terms on relatively small absolute dollar moves and carry additional risks around liquidity, spreads, and potential dilution. The 95% drawdown from the 52-week high is a stark warning for anyone considering chasing this move.

ZCMD — Zhongchao Inc. (+36.9%)

Zhongchao Inc., a Consumer Discretionary company, is trading up +36.9% to $2.04 premarket on 28,832,021 shares — about 4.3× its already-elevated 20-day average of 6,702,570. The relatively modest volume multiple compared to the other movers today is worth noting.

Why it's moving: There are no news headlines on file for ZCMD this morning, and the most recent SEC filing is a 6-K from June 23. The catalyst is unclear, and the move appears to be momentum-driven. With no confirmed fundamental trigger, it may be reacting to broader sympathy buying in the small-cap space, or to activity not yet captured in public filings.

Despite the lack of a clear catalyst, the prior-day technical setup is one of the cleaner ones in today's group: RSI 52, ADX 40, a bullish MA stack, an RS rating of 94, and a technical rank of 90 — placing it in the top 10% of all stocks StockSetups scans. The trend-template score of 4 and conviction of 37/100 suggest the stock was showing relative strength even before this morning. The short-volume ratio of 52% (meaning roughly half of prior-day volume was tied to short sales) is elevated and could create modest covering pressure on an upside move.

The free float is 97% — nearly all shares are freely tradeable — and the market cap is just $1.7 million, making ZCMD one of the smallest names on this list. Micro-cap stocks with large floats and no stated catalyst are particularly prone to giving back premarket gains once the regular session opens and liquidity normalizes.

The bottom line

This morning's five biggest premarket gainers are a mix of news-driven spikes and catalyst-unclear momentum plays — and nearly all of them are micro-cap or nano-cap names with market caps ranging from $1.7 million (ZCMD) to $14.1 million (INLF). That size range is important: the smaller the company, the less liquidity and the more violently prices can swing on relatively small order flow.

LABT is surging on antibiotic-resistance data highlighted in a policy context. INM has a merger-related catalyst backed by a $200M private placement headline. CHAI is riding an AI product expansion announcement that already sparked an after-hours rally. INLF and ZCMD have no confirmed catalysts — their moves look momentum-driven and are harder to underwrite fundamentally.

A few important reminders before the 9:30 AM ET open:

• Premarket prices are not final. Thinner volume and wider spreads before the open mean prices can look very different once the regular session begins. Stocks that are up 50–200% premarket frequently give back a substantial portion of those gains intraday.
• Chasing extended movers is high-risk. Buying into a stock that has already moved 40–224% means you are entering at or near peak excitement — often the highest-risk entry point.
• Patterns and squeezes fail. Even technically strong setups (INM's B grade, ZCMD's bullish MA stack) do not guarantee follow-through, especially when the underlying companies are this small.
• Manage your risk. Position sizing, stop-loss levels, and understanding your own risk tolerance matter more on high-volatility names than anywhere else.

StockSetups scans the full ~12,300-stock US universe every premarket morning — surfacing the biggest movers, detecting chart patterns confirmed by candlesticks, and computing conviction, squeeze, and smart-money scores so you can assess setups quickly. Yesterday's premarket movers are covered in Premarket Stock Movers — July 21, 2026.

This article is for educational and informational purposes only. Nothing here is financial advice or a recommendation to buy or sell any security. Always do your own research.